Mycamine (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the Mycamine drug offered from Astellas Pharma US, Inc.. This Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
NON-PROPRIETARY NAME: | Micafungin sodium |
SUBSTANCE NAME: | MICAFUNGIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2006-06-27 |
END MARKETING DATE: | 0000-00-00 |
Mycamine HUMAN PRESCRIPTION DRUG Details:
Item Description | Mycamine from Astellas Pharma US, Inc. |
LABELER NAME: | Astellas Pharma US, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2006-06-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0469-3211_e337975a-4446-437a-b333-470c20e44f1a |
PRODUCT NDC: | 0469-3211 |
APPLICATION NUMBER: | NDA021506 |
Other MICAFUNGIN SODIUM Pharmaceutical Manufacturers / Labelers: